New Publication on the Gx Inbeneo® Platform Simulator

The Gx Inbeneo® Platform Simulator – a novel instrument to streamline combination product development – has been introduced in the latest publication of the journal ONdrugDelivery, Issue 156 (Jan 2024), pp 97-100.

The Gx Inbeneo® Platform Simulator, which has been developed by Midas Pharma and Gerresheimer, mimics the Gx Inbeneo® autoinjector platform, enabling different combinations of spring force, needle gauges and volume to be tested with a specific drug product.

Thus, it can be a valuable instrument for pharmaceutical companies bridging the gap between pharmaceutical formulation and medical device development. This innovative approach can significantly streamline the drug-device integration process and reduce time to market for patient-centric combination products.

Primavessy D, Saaler-Reinhardt S, Maksymowicz K, Stockton M, “A Novel Instrument to Streamline Combination Product Development”. ONdrugDelivery, Issue 156 (Jan 2024), pp 97–100.


Find the best suitable configuration for your formulation with our toolbox.

Your Contact

Dr. Matthias Bauch

Dr. Matthias Bauch

Biotechnology & Devices
Global Vice President

Midas Pharma GmbH
Rheinstraße 49
55218 Ingelheim
Send E-Mail

Share this page